1. Home
  2. TALO vs AMPH Comparison

TALO vs AMPH Comparison

Compare TALO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talos Energy Inc.

TALO

Talos Energy Inc.

HOLD

Current Price

$11.01

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.05

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TALO
AMPH
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.3B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
TALO
AMPH
Price
$11.01
$26.05
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$14.30
$31.00
AVG Volume (30 Days)
2.1M
383.1K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$1,872,554,000.00
$723,305,000.00
Revenue This Year
N/A
$1.35
Revenue Next Year
N/A
$5.10
P/E Ratio
N/A
$11.49
Revenue Growth
0.06
N/A
52 Week Low
$6.23
$20.39
52 Week High
$12.20
$41.84

Technical Indicators

Market Signals
Indicator
TALO
AMPH
Relative Strength Index (RSI) 49.17 49.96
Support Level $10.64 $25.16
Resistance Level $11.23 $26.52
Average True Range (ATR) 0.39 0.86
MACD -0.13 -0.11
Stochastic Oscillator 24.44 36.02

Price Performance

Historical Comparison
TALO
AMPH

About TALO Talos Energy Inc.

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: